YCG
INSM icon

Yeomans Consulting Group’s Insmed INSM Stock Holding History

Yeomans Consulting Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$326K Buy
+1,871
New +$341K 0.1% 94

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Yeomans Consulting Group's INSM Position: Q4 2025 in Review

Yeomans Consulting Group opened a new position in Insmed (INSM) in Q4 2025: 1,871 shares worth $326K. The stake represents 0.1% of the portfolio and ranks #94 among its holdings.

676 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Yeomans Consulting Group held 1,871 shares of Insmed worth $326K as of Q4 2025.
  • Insmed was a new Yeomans Consulting Group position in Q4 2025.
  • Insmed made up 0.1% of Yeomans Consulting Group's portfolio in Q4 2025, its #94 holding.
  • 676 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Yeomans Consulting Group's 13F filing for Q4 2025, filed 7 Jan 2026.